From development complexity to a clear evidence strategy
Turning disconnected development information into a structured foundation for strategic decision-making.
The starting point
Pharmaceutical development generates information at multiple levels.
Formulation work creates technical knowledge; analytical characterization creates product understanding; development activities generate additional evidence; and clinical or patient-focused work can add another dimension.
Yet information alone does not automatically become useful evidence.
Challenge
To establish a clearer relationship between development evidence and strategic decision-making: understanding how individual pieces of information fit together and what the collective evidence means for the next scientific, regulatory or commercial decision.
Objective
Establish a structured evidence framework that connects development information with future decisions, identifies important evidence gaps, distinguishes information from decision-relevant evidence and creates a foundation for scientific, regulatory and commercial discussions.
Approach
- 01Map the development questionDefine what the program needs to understand or demonstrate.
- 02Structure the evidenceConsider technical and broader evidence as a connected system.
- 03Identify evidence gapsDistinguish uncertainties that could materially affect future decisions.
- 04Connect evidence with strategyInterpret scientific evidence in the context of the wider development program.
- 05Establish an evidence frameworkCreate a structure connecting evidence, gaps and strategic priorities.
From data to decision
- 01Data is generated
- 02Evidence is structured
- 03Evidence is interpreted
- 04Gaps become visible
- 05Development priorities become clearer
- 06Strategic decisions become better informed
Four perspectives on the same evidence
| Perspective | Key question | Strategic value |
|---|---|---|
| Scientific | What does the evidence establish about the product and its development? | Distinguish established understanding from remaining uncertainty. |
| Regulatory | How can the evidence contribute to future regulatory considerations? | Create a deliberate foundation for future regulatory considerations. |
| Commercial | How can the evidence inform future product or commercial strategy? | Contribute to informed product and commercial strategy discussions. |
| Development | What does the evidence clarify about what should happen next? | Clarify evidence gaps and future development priorities. |
Result
The engagement established a clearer framework for understanding development evidence and its strategic relevance.
It created a structured way to consider how evidence contributes to the wider development program.
Key deliverables
- 01Development evidence framework
- 02Evidence-gap identification
- 03Structured interpretation of development information
- 04Scientific strategy considerations
- 05Regulatory strategy considerations
- 06Commercial strategy considerations
- 07Development decision framework
